Gravar-mail: Clinical Validation of a Novel Diagnostic HIV-2 Total Nucleic Acid Qualitative Assay Using the Abbott m2000 Platform: Implications for Complementary HIV-2 Nucleic Acid Testing for the CDC 4(th) Generation HIV Diagnostic Testing Algorithm